Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults
This study has been completed.
United States Agency for International Development (USAID)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
First received: December 27, 2005
Last updated: November 19, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||September 2013|
|Primary Completion Date:||June 2011 (Final data collection date for primary outcome measure)|
Rosen S, Ketlhapile M, Sanne I, Desilva MB. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS. 2008 Jul;22 Suppl 1:S131-9. doi: 10.1097/01.aids.0000327634.92844.91.
Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Characteristics of patients accessing care and treatment for HIV/AIDS at public and nongovernmental sites in South Africa. J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug;7(4):200-7. doi: 10.1177/1545109708320684. Epub 2008 Jul 14.
Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J. 2007 Jul;97(7):524-9.
Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, Ketlhapile M, Sanne I. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One. 2010 Sep 14;5(9):e12731. doi: 10.1371/journal.pone.0012731.